GAMMA Investing LLC

Position in ALKS — Alkermes plc.

CIK 2010235 FOSTER CITY, CA

Position in ALKS

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$351,308

+$160,895 QoQ

Shares Held

6,705

+24.5% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

of 6 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

GAMMA Investing LLC holds $6,662,328 across 41 Drug Manufacturers - Specialty & Generic names. ALKS ranks #7 (5.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	1,769	$958,497
2	ZTS	Zoetis Inc.	12,047	$865,697
3	VTRS	Viatris Inc	43,632	$692,876
4	NBIX	Neurocrine Biosciences Inc	3,714	$625,957
5	TEVA	Teva Pharmaceutical Industries Ltd	11,361	$384,910
6	LNTH	Lantheus Holdings, Inc.	3,348	$371,427
7	ALKS	Alkermes plc. This page	6,705	$351,308
8	HLN	Haleon plc	34,810	$324,777

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$351,308	6,705	+24.5%	Shares	Defined	2026-07-07
2026-03-31	$190,413	5,385	+0.4%	Shares	Defined	2026-04-06
2025-12-31	$150,056	5,363	+22.1%	Shares	Defined	2026-01-05
2025-09-30	$131,820	4,394	-11.5%	Shares	Defined	2025-10-02
2025-06-30	$141,991	4,963	-8.0%	Shares	Defined	2025-07-14
2025-03-31	$178,175	5,396	+31.9%	Shares	Defined	2025-04-15
2024-12-31	$117,657	4,091	-2.7%	Shares	Defined	2025-01-03
2024-09-30	$117,669	4,204	+83.8%	Shares	Defined	2024-10-07
2024-06-30	$55,116	2,287	+44.4%	Shares	Defined	2024-07-02
2024-03-31	$42,878	1,584	+21.5%	Shares	Defined	2024-04-05
2023-12-31	$36,172	1,304	—	Shares	Defined	2024-02-01
No filing history on record for this holder in this stock.